论文部分内容阅读
本文随机将术后复发件恶性腹水的卯巢浆液性囊腺癌病人分成３组，１组给予常规全身化疗；２组静脉及腹腔单独用ＤＤＰ化疗；３组给予静脉及腹腔联合化疗．结果显示，治疗后２、３组病人腹水完全缓解率及ＣＡ１２５值的降低明显优于１组，且有极显著差异，２组与３组之间差异无显著性；３组病人化疗后临床表现好转，食欲增进，全身状况好转，骨髓抑制程度轻，与１组、２组相比，３组治疗方法疗效好，毒副作用小．
This article randomized the postoperative recurrence of malignant ascites seminoma patients with serous cystadenocarcinoma were divided into three groups, one group given conventional systemic chemotherapy; two groups of intravenous and intraperitoneal DDP chemotherapy alone; three groups were given intravenous and intraperitoneal chemotherapy. The results showed that after treatment, the complete remission rate of ascites and the reduction of CA125 in patients in group 2 and group 3 were significantly better than those in group 1, with significant differences. There was no significant difference between groups 2 and 3; after treatment, the clinical manifestations Improvement, increased appetite, general condition improved, bone marrow suppression was light, compared with 1 group, 2 groups, 3 groups of curative effect is good, the side effects are small.